ETOPOSIDE

73091 reported adverse events

Drug classes: Topoisomerase Inhibitor [EPC]

These side effects are most commonly reported by patients taking ETOPOSIDE:

# Side effect Count
0 OFF LABEL USE 8156
1 FEBRILE NEUTROPENIA 7641
2 NEUTROPENIA 4993
3 DRUG INEFFECTIVE 4696
4 DISEASE PROGRESSION 4456
5 THROMBOCYTOPENIA 4072
6 PYREXIA 3343
7 ANAEMIA 3307
8 SEPSIS 2968
9 PRODUCT USE IN UNAPPROVED INDICATION 2947
See all common reactions for ETOPOSIDE

ETOPOSIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LYMPHOID TISSUE HYPOPLASIA 144 0.9796
1 THYMUS HYPOPLASIA 148 0.8706
2 HUMAN BOCAVIRUS INFECTION 133 0.7074
3 RHABDOID TUMOUR 31 0.6200
4 OVARIAN GERM CELL TERATOMA 37 0.4625
5 CHORIOCARCINOMA 30 0.4110
6 BASAL GANGLION DEGENERATION 34 0.3579
7 MEDULLOBLASTOMA RECURRENT 40 0.3540
8 RENAL SALT-WASTING SYNDROME 136 0.3487
9 NEPHROBLASTOMA 42 0.3307
See all enriched reactions for ETOPOSIDE